Operating Income (Loss) of Core Scientific, Inc./tx from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Core Scientific, Inc./tx quarterly and annual Operating Income (Loss) in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Core Scientific, Inc./tx Operating Income (Loss) for the quarter ending 30 Sep 2025 was $57,425,000, a 39% decline year-over-year.
  • Core Scientific, Inc./tx Operating Income (Loss) for the twelve months ending 30 Sep 2025 was $166,088,000, a 777% decline year-over-year.
  • Core Scientific, Inc./tx annual Operating Income (Loss) for 2024 was $19,196,000, a 314% decline from 2023.
  • Core Scientific, Inc./tx annual Operating Income (Loss) for 2023 was $8,961,000.
  • Core Scientific, Inc./tx annual Operating Income (Loss) for 2022 was $2,109,553,000, a 1704% decline from 2021.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Core Scientific, Inc./tx Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $166,088,000 $57,425,000 -$16,206,000 -39% 01 Jul 2025 30 Sep 2025 10-Q 24 Oct 2025 2025 Q3
Q2 2025 $149,882,000 $26,284,000 -$32,863,000 -500% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $117,019,000 $42,596,000 -$97,823,000 -177% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $19,196,000 $39,783,000 -$43,717,000 -1111% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
Q3 2024 $24,521,000 $41,219,000 -$29,175,000 -242% 01 Jul 2024 30 Sep 2024 10-Q 24 Oct 2025 2025 Q3
Q2 2024 $53,696,000 $6,579,000 -$2,890,000 -31% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025 2025 Q2
Q1 2024 $56,586,000 $55,227,000 +$47,625,000 +626% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 $8,961,000 $3,934,000 +$640,013,000 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $631,052,000 $12,044,000 +$389,330,000 +97% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $1,020,382,000 $9,469,000 +$1,054,852,000 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $2,075,234,000 $7,602,000 +$34,319,000 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $2,109,553,000 $636,079,000 -$738,237,000 -723% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $1,371,316,000 $401,374,000 -$406,158,000 -8490% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023 2023 Q3
Q2 2022 $965,158,000 $1,045,383,000 -$1,060,909,000 -6833% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023 2023 Q2
Q1 2022 $95,751,000 $26,717,000 -$35,743,000 -396% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $131,494,000 $102,158,000 +$102,168,400 01 Oct 2021 31 Dec 2021 10-K 13 Mar 2024 2023 FY
Q3 2021 $29,325,600 $4,784,000 01 Jul 2021 30 Sep 2021 10-Q 22 Nov 2022 2022 Q3
Q2 2021 $15,526,000 01 Apr 2021 30 Jun 2021 10-Q 22 Aug 2022 2022 Q2
Q1 2021 $9,026,000 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q4 2020 $10,400* 29 Dec 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY

Core Scientific, Inc./tx Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $19,196,000 -$28,157,000 -314% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
2023 $8,961,000 +$2,118,514,000 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $2,109,553,000 -$2,241,047,000 -1704% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $131,494,000 +$137,821,000 01 Jan 2021 31 Dec 2021 10-K 13 Mar 2024 2023 FY
2020 $6,327,000 01 Jan 2020 31 Dec 2020 10-K 04 Apr 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.